Cytori Cell Research Institute, Inc. (3750.T)
JPY 666.0
(0.3%)
JPY 666.0
(0.3%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 138.15 Million JPY | 113.03% |
| 2022 | -1.05 Billion JPY | -1265.32% |
| 2021 | -77.63 Million JPY | 90.67% |
| 2020 | -831.86 Million JPY | -360.77% |
| 2019 | 319 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -242 Million JPY | -135.03% |
| 2023 Q2 | -282.04 Million JPY | -74.86% |
| 2023 Q1 | -161.29 Million JPY | 52.16% |
| 2023 Q4 | 690.79 Million JPY | 732.01% |
| 2023 Q3 | -109.3 Million JPY | 61.25% |
| 2023 FY | 138.15 Million JPY | 113.03% |
| 2022 Q3 | -161.51 Million JPY | 40.99% |
| 2022 FY | -1.05 Billion JPY | -1265.32% |
| 2022 Q4 | -337.14 Million JPY | -108.73% |
| 2022 Q2 | -273.72 Million JPY | 0.0% |
| 2021 FY | -77.63 Million JPY | 90.67% |
| 2020 FY | -831.86 Million JPY | -360.77% |
| 2019 FY | 319 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 64.022% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | 126.22% |
| GNI Group Ltd. | 8.09 Billion JPY | 98.293% |
| Linical Co., Ltd. | 338.26 Million JPY | 59.158% |
| Trans Genic Inc. | 4.08 Million JPY | -3282.007% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 109.608% |
| Soiken Holdings Inc. | -662.2 Million JPY | 120.863% |
| AnGes, Inc. | -7.43 Billion JPY | 101.858% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 110.725% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 101.921% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 25.999% |
| NanoCarrier Co., Ltd. | -780 Million JPY | 117.712% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 111.983% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 111.427% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | 117.006% |
| RaQualia Pharma Inc. | -323.66 Million JPY | 142.685% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 111.324% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 109.715% |
| PeptiDream Inc. | 3.03 Billion JPY | 95.449% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 107.127% |
| Ribomic Inc. | -1.02 Billion JPY | 113.489% |
| SanBio Company Limited | -2.64 Billion JPY | 105.225% |
| Healios K.K. | -3.82 Billion JPY | 103.614% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 111.828% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 109.275% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 109.665% |
| StemRIM | -2.02 Billion JPY | 106.833% |
| CellSource Co., Ltd. | 923.14 Million JPY | 85.034% |
| FunPep Company Limited | -933.41 Million JPY | 114.801% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 116.175% |
| Stella Pharma Corporation | -763.74 Million JPY | 118.089% |
| TMS Co., Ltd. | -960.04 Million JPY | 114.391% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 112.226% |
| Cuorips Inc. | -632.18 Million JPY | 121.854% |
| K Pharma,Inc. | 260.33 Million JPY | 46.931% |
| Takara Bio Inc. | 1.48 Billion JPY | 90.665% |
| ReproCELL Incorporated | -31.41 Million JPY | 539.774% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | -423.751% |
| StemCell Institute Inc. | 310.98 Million JPY | 55.574% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 3.502% |
| CellSeed Inc. | -846.53 Million JPY | 116.32% |